Wogonin suppresses arrhythmias, inflammatory responses, and apoptosis induced by myocardial ischemia/reperfusion in rats

Journal of Cardiovascular Pharmacology

Volumn 58, Issue 2, 2011, Pages 133-142

  Lee, Yen Mei ^a,b   Cheng, Pao Yun ^c   Chen, Shu Ying ^d   Chung, Ming Tzeung ^e   Sheu, Joen Rong ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d HUNGKUANG UNIVERSITY   (Taiwan)

^e TAO YUAN GENERAL HOSPITAL   (Taiwan)

Author keywords

apoptosis; arrhythmias; monocyte chemoattractant protein 1; myocardial ischemia reperfusion injury; nuclear factor B; p38 mitogen activated protein kinase; wogonin

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIINFLAMMATORY AGENT; APOPTOSIS INHIBITOR; CASPASE 3; CREATINE KINASE; I KAPPA B ALPHA; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; SUPEROXIDE; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR; WOGONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; IN VIVO STUDY; MALE; MORTALITY; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; ARRHYTHMIAS, CARDIAC; BLOTTING, WESTERN; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVANONES; HEMODYNAMICS; MALE; MYOCARDIAL REPERFUSION INJURY; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDES;

EID: 80051791387     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31821a5078     Document Type: Article

References (46)

1. Akar JG, Akar FG. Regulation of ion channels and arrhythmias in the ischemic heart. J Electrocardiol. 2007;40:S37-S41.
2. Cannon RO III. Mechanisms, management and future directions for reperfusion injury after acute myocardial infarction. Natl Clin Pract Cardiovasc Med. 2005;2:88-94.
3. Frangogiannis NG. The role of the chemokines in myocardial ischemia and reperfusion. Curr Vasc Pharmacol. 2004;2:163-174.
4. Kis A, Yellon DM, Baxter GF. Role of nuclear factor-kappa B activation in acute ischaemia-reperfusion injury in myocardium. Br J Pharmacol. 2003;138:894-900.
5. Morishita R, Sugimoto T, Aoki M, et al. In vivo transfection of cis element ''decoy'' against nuclear factor-kappaB binding site prevents myocardial infarction. Natl Med. 1997;3:894-899.
6. Pye J, Ardeshirpour F, McCain A, et al. Proteasome inhibition ablates activation of NF-kB in myocardial reperfusion and reduces reperfusion injury. Am J Physiol Heart Circ Physiol. 2003;284:H919-H926.
7. Krijnen PA, Nijmeijer R, Meijer CJ, et al. Apoptosis in myocardial ischemia and infarction. J Clin Pathol. 2002;55:801-811.
8. Gao Z, Huang K, Yang X, et al. Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi. Biochim Biophys Acta. 1999;1472:643-650.
9. Kim HK, Cheon BS, Kim YH, et al. Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships. Biochem Pharmacol. 1999;58:759-765.
10. Wakabayashi I, Yasui K. Wogonin inhibits inducible prostaglandin E2 production in macrophages. Eur J Pharmacol. 2000;406:477-481.
11. Chang YL, Shen JJ, Wung BS, et al. Chinese herbal remedy wogonin inhibits monocyte chemotactic protein-1 gene expression in human endothelial cells. Mol Pharmacol. 2001;60:507-513.
12. Nakamura N, Hayasaka S, Zhang XY, et al. Effects of baicalin, baicalein, and wogonin on interleukin-6 and interleukin-8 expression, and nuclear factor-kB binding activities induced by interleukin-1 in human retinal pigment epithelial cell line. Exp Eye Res. 2003;77:195-202.
13. Park BK, Heo MY, Park H, et al. Inhibition of TPA-induced cyclooxygenase- 2 expression and skin inflammation in mice by wogonin, a plant flavone from Scutellaria radix. Eur J Pharmacol. 2001;425:153-157.
14. Shen SC, Lee WR, Lin HY, et al. In vitro and in vivo inhibitory activities of rutin, wogonin, and quercetin on lipopolysaccharide-induced nitric oxide and prostaglandin E2 production. Eur J Pharmacol. 2002;446:187-194.
15. Kane KA, Leprán I, McDonald FM, et al. The effects of prolonged oral administration of a new antidysrhythmic drug (Org 6001) on coronary artery ligation dysrhythmias in conscious and anesthetized rats. J Cardiovasc Pharmacol. 1980;2:411-423.
16. Clark C, Foreman MI, Kane KA, et al. Coronary artery ligation in anesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size. J Pharmacol Methods. 1980;3:357-368.
17. Manning AS, Coltart DJ, Hearse DJ. Ischemia and reperfusion-induced arrhythmias in the rat. Effects of xanthine oxidase inhibition with allopurinol. Circ Res. 1984;55:545-548.
18. Curtis MJ, Macleod BA, Walker MJ. Models for the study of arrhythmias in myocardial ischaemia and infarction: The use of the rat. J Mol Cell Cardiol. 1987;19:399-419.
19. Chung MT, Cheng PY, Lam KK, et al. Cardioprotective effects of longterm treatment with raloxifene, a selective estrogen receptor modulator, on myocardial ischemia/reperfusion injury in ovariectomized rats. Menopause. 2010;17:127-134.
20. Walker MJ, Curtis MJ, Hearse DJ, et al. The Lambeth Conventions: Guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res. 1988;22:447-455.
21. Johnston KM, MacLeod BA, Walker MJ. Effects of aspirin and prostacyclin on arrhythmias resulting from coronary artery ligation and on infarct size. Br J Pharmacol. 1983;78:29-37.
22. Curtis MJ, Hearse DJ. Ischaemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: Implications for mechanisms of initiation and maintenance of ventricular fibrillation. J Mol Cell Cardiol. 1989;21:21-40.
23. Tsuchihashi K, Curtis MJ. Influence of tedisamil on the initiation and maintenance of ventricular fibrillation: Chemical defibrillation by Ito blockade? J Cardiovasc Pharmacol. 1991;18:445-456.
24. Moss NC, Stansfield WE, Willis MS, et al. IKKb inhibition attenuates myocardial injury and dysfunction following acute ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2007;293:H2248-H2253.
25. Chen SY, Hsiao G, Hwang HR, et al. Tetramethylpyrazine induces heme oxygenase-1 expression and attenuates myocardial ischemia/reperfusion injury in rats. J Biomed Sci. 2006;13:731-740.
26. Dudley SC Jr, Hoch NE, McCann LA, et al. Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: Role of the NADPH and xanthine oxidases. Circulation. 2005;112:1266-1273.
27. Lanza GA, Fox K, Crea F. Heart rate: A risk factor for cardiac diseases and outcomes? Pathophysiology of cardiac diseases and the potential role of heart rate slowing. Adv Cardiol. 2006;43:1-16.
28. Hamilton KL. Antioxidants and cardioprotection. Med Sci Sports Exerc. 2007;39:1544-1553.
29. Marczin N, Bundy RE, Hoare GS, et al. Redox regulation following cardiac ischemia and reperfusion. Coron Artery Dis. 2003;14:123-133.
30. Granger DN, Kubes P. The microcirculation and inflammation: Modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol. 1994;55:662-675.
31. Hall G, Hasday JD, Rogers TB. Regulating the regulator: NF-kB signaling in heart. J Mol Cell Cardiol. 2006;41:580-591.
32. Squadrito F, Deodato B, Squadrito G, et al. Gene transfer of IkappaBalpha limits infarct size in a mouse model of myocardial ischemia-reperfusion injury. Lab Invest. 2003;83:1097-1104.
33. Melgarejo E, Medina MA, Sanchez-Jimenes F, et al. Monocyte chemoattractant protein-1: A key mediator in inflammatory processes. Int J Biochem Cell Biol. 2009;41:998-1001.
34. Kumar AG, Ballantyne CM, Michael LH, et al. Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium. Circulation. 1997;95:693-700.
35. Ono K, Matsumori A, Furukawa Yet al. Prevention of myocardial reperfusion injury in rats by an antibody against monocyte chemotactic and activating factor/monocyte chemoattractant protein-1. Lab Invest. 1999;79:195-203.
36. Sung FL, Zhu TY, Au-Yeung KKW, et al. Enhanced MCP-1 expression during ischemia/reperfusion injury is mediated by oxidative stress and NF-kB. Kidney Int. 2002;62:1160-1170.
37. Ravingerova T, Barancik M, Strniskova M. Mitogen-activated protein kinases: A new therapeutic target in cardiac pathology. Mol Cell Biochem. 2003;247:127-138.
38. Zarubin T, Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 2005;15:11-18.
39. Ma XL, Kumar S, Gao F, et al. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation. 1999;99: 1685-1691.
40. Schneider S, Chen W, Hou J, et al. Inhibition of p38 MAPK alpha/ beta reduces ischemic injury and does not block protective effects of preconditioning. Am J Physiol Heart Circ Physiol. 2001;280:H499-H508.
41. Logue SE, Gustaffson AB, Samali A, et al. Ischemia/reperfusion injury at the intersection with cell death. J Mol Cell Cardiol. 2005;38:21-33.
42. Yaginuma H, Sato N, Homma S, et al. Roles of caspases in the programmed cell death of motoneurons in vivo. Arch Histol Cytol. 2001; 64:461-474.
43. Zhao ZQ, Vinten-Johansen J. Myocardial apoptosis and ischemic preconditioning. Cardiovasc Res. 2002;55:438-455.
44. Chang WT, Shao ZH, Yin JJ, et al. Comparative effects of flavonoids on oxidant scavenging and ischemia-reperfusion injury in cardiomyocytes. Eur J Pharmacol. 2007;566:58-66.
45. Lee H, Kim YO, Kim H, et al. Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia. FASEB J. 2003;17:1943-1944.
46. Cho J, Lee HK. Wogonin inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion. Biol Pharm Bull. 2004;27: 1561-1564.